114 related articles for article (PubMed ID: 31937053)
1. [The expression and significance of chromobox protein homolog 2 in breast cancer].
Guo XH; Zhang JY; Jiao DC; Zhu JJ; Ma YZ; Yang Y; Xiao H; Liu ZZ
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(2):130-135. PubMed ID: 31937053
[No Abstract] [Full Text] [Related]
2. Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer.
Chen WY; Zhang XY; Liu T; Liu Y; Zhao YS; Pang D
Oncol Lett; 2017 Mar; 13(3):1149-1156. PubMed ID: 28454227
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
Li J; Guo ZX; Chen JA; Xue C; Sun LL; Ren ZG; Li A; Cui GY; Yu ZJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):192-197. PubMed ID: 30929335
[No Abstract] [Full Text] [Related]
4. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
Li X; Gou J; Li H; Yang X
Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses.
Zhou H; Xiong Y; Liu Z; Hou S; Zhou T
Cancer Cell Int; 2021 Jul; 21(1):402. PubMed ID: 34321009
[TBL] [Abstract][Full Text] [Related]
6. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer.
Iqbal MA; Siddiqui S; Ur Rehman A; Siddiqui FA; Singh P; Kumar B; Saluja D
Mol Oncol; 2021 May; 15(5):1450-1465. PubMed ID: 33400401
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of the Expression and Prognosis of chromobox Family Members in Breast Cancer.
Wang L; Zhao L; Zhang Y; Shao S; Ning Q; Zhao X; Luo M
Clin Breast Cancer; 2023 Jun; 23(4):e206-e218. PubMed ID: 36890004
[TBL] [Abstract][Full Text] [Related]
8. CBX2 Expression in Colorectal Mucosa-adenoma-adenocarcinoma Sequence.
Wang B; Huang M; Wang X; Tseng Y; Luo F; Liu J
J Coll Physicians Surg Pak; 2021 Sep; 31(9):1051-1056. PubMed ID: 34500520
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CBX2 in breast cancer promotes tumor progression through the PI3K/AKT signaling pathway.
Zheng S; Lv P; Su J; Miao K; Xu H; Li M
Am J Transl Res; 2019; 11(3):1668-1682. PubMed ID: 30972192
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of distinct CBX family members in breast cancer.
Liang YK; Lin HY; Chen CF; Zeng D
Oncotarget; 2017 Nov; 8(54):92375-92387. PubMed ID: 29190923
[TBL] [Abstract][Full Text] [Related]
11. Polycomb chromobox Cbx2 enhances antiviral innate immunity by promoting Jmjd3-mediated demethylation of H3K27 at the Ifnb promoter.
Sun D; Cao X; Wang C
Protein Cell; 2019 Apr; 10(4):285-294. PubMed ID: 30357595
[TBL] [Abstract][Full Text] [Related]
12. CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma.
Mao J; Tian Y; Wang C; Jiang K; Li R; Yao Y; Zhang R; Sun D; Liang R; Gao Z; Wang Q; Wang L
J Cancer; 2019; 10(12):2706-2719. PubMed ID: 31258779
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma.
Piqué DG; Montagna C; Greally JM; Mar JC
Br J Cancer; 2019 Apr; 120(7):746-753. PubMed ID: 30820027
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Roles of Chromobox Family Members in Gastric Cancer: A Study Based on Multiple Datasets.
Chen ZY; Sun SX; Zhu SX; Bu J
Biomed Res Int; 2020; 2020():5306509. PubMed ID: 33344640
[TBL] [Abstract][Full Text] [Related]
15. Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes.
Park S; Choi J; Song JK; Jang B; Maeng YH
Med Mol Morphol; 2024 Mar; 57(1):11-22. PubMed ID: 37553450
[TBL] [Abstract][Full Text] [Related]
16. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
17. The predictive significance of chromobox family members in prostate cancer in humans.
Xu X; Lai C; Luo J; Shi J; Guo K; Hu J; Mulati Y; Xiao Y; Kong D; Liu C; Huang J; Xu K
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38427207
[TBL] [Abstract][Full Text] [Related]
18. Chromobox 2 Expression Predicts Prognosis After Curative Resection of Oesophageal Squamous Cell Carcinoma.
Ueda S; Kanda M; Sato Y; Baba H; Nakamura S; Sawaki K; Shimizu D; Motoyama S; Fujii T; Kodera Y; Nomoto S
Cancer Genomics Proteomics; 2020; 17(4):391-400. PubMed ID: 32576584
[TBL] [Abstract][Full Text] [Related]
19. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
20. An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma.
Zhou F; Chen L; Lu P; Cao Y; Deng C; Liu G
BMC Cancer; 2023 Jul; 23(1):641. PubMed ID: 37430195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
